Table 3.

Univariate DSS for Gastric

			N (#events)	HR	[95% CI]	p-value
Modality	Variable	Level
PET	SUVmax (Baseline)		72 (25)	0.98	[0.93 – 1.04]	0.52
	SUVmax (PreOp)		72 (25)	1.02	[0.97 – 1.07]	0.50
	PET Response (continuous)		72 (25)	1.00	[0.99 – 1.00]	0.14
	SUVmax Response (Median Cut)	< 32.5%	36 (15)	1.88	[0.84–4.18]	0.12
		≥ 32.5%	36 (10)	REF
	SUVmax (Published Cut)	< 35%	38 (16)	1.99	[0.88 – 4.52]	0.10
		≥ 35%	34 (9)	REF
Pathology	T Stage	T0–T1b	19 (2)	REF
		T2	11 (1)	0.77	[0.07 – 8.52]	0.83
		T3–T4	42 (22)	6.69	[1.57 – 28.50]	0.010
	Overall Stage	0–I	21 (2)	REF
		II	26 (4)	1.96	[0.36 – 10.70]	0.44
		III–IV	25 (19)	15.2	[3.51 – 65.89]	0.0003
	N Stage	N0	31 (3)	REF
		N1+	41 (22)	8.30	[2.48 – 27.81]	0.0006
	Pathologic Responseˆ		72 (25)	0.86	[0.77 – 0.97]	0.016
		< 35%	36 (16)	2.20	[0.97 – 4.98]	0.06
		≥ 35%	36 (9)	REF
	LVI	No	32 (4)	REF
		Yes	40 (21)	5.30	[1.81 – 15.47]	0.002

^ˆHR in increments of 10 units